Spatial analysis of cellular arrangement using quantitative, single-cell imaging of protein multiplexing

Single cell phenotyping using molecular or protein multiplexing techniques is gaining momentum, especially in the characterization of cancer and the tumor microenvironment. It has proven to be particularly useful in studying the extent of heterogeneity in cancer, and in the profiling of the immune environment to assess whether certain cell subsets could be predictive of treatment response. Using a sequential protein marker labelling system called Multiplex Immunofluorescence (MxIF, GE Research), we have developed quantitative image analysis and computational tools for phenotyping individual immune and cancer cells for various cancer types. The expressions of T cell markers CD3, CD8, macrophage markers CD68, immune checkpoint proteins PD-1 and PD-L1, together with proliferative marker (Ki67) and cancer-specific marker PCK (pan-Cytokeratin) were studied on single 4um sections of formalin-fixed, paraffinembedded (FFPE) ovarian cancer tissue sections. We explored the composition of immune phenotype using t-SNE and quantified cell densities and marker co-expression patterns using binary cell counting. In addition to phenotyping immune cell types, their spatial localizations were analyzed. Neighborhood analysis was conducted using co-occurrence matrices to determine the number of times that a particular cell type is proximal to one another. Cell-to-cell spatial relationship was assessed by quantifying the Euclidean distances between individual cell types. These tools are being applied to specimens from an immunotherapy clinical trial to evaluate the dynamic changes in immune phenotype during the course of immune blockade therapy.

[1]  Kieran R. Campbell,et al.  Clonal fitness inferred from time-series modelling of single-cell cancer genomes , 2021, Nature.

[2]  S. Tavaré,et al.  Landscapes of cellular phenotypic diversity in breast cancer xenografts and their impact on drug response , 2021, Nature Communications.

[3]  M. Merad,et al.  PD-L1 expression by dendritic cells is a key regulator of T-cell immunity in cancer , 2020, Nature Cancer.

[4]  Nicolai J. Birkbak,et al.  Geospatial immune variability illuminates differential evolution of lung adenocarcinoma , 2020, Nature Medicine.

[5]  F. Hodi,et al.  Subsets of exhausted CD8+ T cells differentially mediate tumor control and respond to checkpoint blockade , 2019, Nature Immunology.

[6]  Daniel E. Speiser,et al.  Intratumoral Tcf1+PD‐1+CD8+ T Cells with Stem‐like Properties Promote Tumor Control in Response to Vaccination and Checkpoint Blockade Immunotherapy , 2019, Immunity.

[7]  Jack Cuzick,et al.  Relevance of Spatial Heterogeneity of Immune Infiltration for Predicting Risk of Recurrence After Endocrine Therapy of ER+ Breast Cancer , 2018, Journal of the National Cancer Institute.

[8]  A. Whittemore,et al.  Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer , 2017, JAMA oncology.

[9]  C. Drake,et al.  Immune checkpoint blockade: a common denominator approach to cancer therapy. , 2015, Cancer cell.

[10]  Z. Szallasi,et al.  Spatial and temporal diversity in genomic instability processes defines lung cancer evolution , 2014, Science.

[11]  Steven J. M. Jones,et al.  Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma , 2014, Science.

[12]  Qing Li,et al.  Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue , 2013, Proceedings of the National Academy of Sciences.

[13]  Carlos Caldas,et al.  The implications of clonal genome evolution for cancer medicine. , 2013, The New England journal of medicine.

[14]  J. Reis-Filho,et al.  Genomic and mutational profiling of ductal carcinomas in situ and matched adjacent invasive breast cancers reveals intra‐tumour genetic heterogeneity and clonal selection , 2012, The Journal of pathology.

[15]  Drew M. Pardoll,et al.  The blockade of immune checkpoints in cancer immunotherapy , 2012, Nature Reviews Cancer.

[16]  J. Troge,et al.  Tumour evolution inferred by single-cell sequencing , 2011, Nature.

[17]  Ryan D. Morin,et al.  Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution , 2009, Nature.

[18]  Geoffrey E. Hinton,et al.  Visualizing Data using t-SNE , 2008 .